Fresh Ginger, Powder or Capsules: The Molecule Decides

The question is poorly framed, because the two do not contain the same molecules. Fresh ginger is rich in gingerols. Drying and heat transform some of these gingerols into shogaols, through the loss of a water molecule. An analysis of commercial dried ginger found slightly reduced gingerols and increased shogaols compared to fresh. Both families are active, with different profiles. What matters is not fresh or dry, it's how much of each, and this cannot be seen with the naked eye.

Gingerols are the predominant pungent compounds of the fresh rhizome, with 6-gingerol being the most abundant, along with 8- and 10-gingerols. These are what give fresh ginger its sharp pungency and carry much of its activity studied in the laboratory. They are thermally unstable: heat dehydrates them into shogaols.

Shogaol is the dehydrated form of gingerol. It is a minor component in the fresh rhizome and increases with drying, storage, and cooking. It gives dried ginger its warmer and more persistent pungency. Several laboratory studies attribute to it a more powerful activity than that of the corresponding gingerol, which explains why manufacturers are interested in shogaol-rich extracts. This superiority is established in vitro and in animals, but not demonstrated in humans.

Because they are not the same molecules creating the pungency. The gingerol in fresh ginger gives a sharp, fresh pungency. The shogaol in dried ginger gives a warmer, deeper, and more persistent pungency. The change in taste that everyone knows between a grated rhizome and a cooking powder is the sensory translation of a real chemical change.

It modifies its composition. One study dried fresh ginger by freeze-drying, at room temperature, or in an oven at 60 and 80 degrees, then extracted at different temperatures. The 6-shogaol content increased with drying and extraction temperature, up to seven times more between the coldest and hottest process. Another analysis of commercial dried ginger identified 115 compounds, including 31 new ones formed by thermal degradation. Drying does not concentrate ginger, it transforms it.

It is different. Dried ginger has more shogaols, fresh has more gingerols, and clinical trials on nausea or painful menstruation used dried rhizome powder, which supports this form if one wants to reproduce what has been studied. But nothing demonstrates in humans that one profile is superior to the other for a given use. The decisive advantage of powder lies elsewhere: it can be dosed.

It transforms them. Cooking, like drying, dehydrates gingerols into shogaols, and an analysis of commercial dried ginger attributes some of its compounds to thermal degradation that mimics cooking. Cooked ginger is therefore not inactive, it has a different profile from fresh, richer in shogaols. What is lacking are clinical data comparing one to the other.

Its composition evolves over time, light, and heat: gingerols continue to convert to shogaols, then the shogaols themselves degrade. Powder stored for a long time in a warm cupboard no longer has the profile of fresh powder from the batch. An opaque, closed container, kept cool and dry, and a recent manufacturing date are the useful benchmarks.

A trial in 27 volunteers who took 100 mg to 2 g of ginger tracked gingerols and 6-shogaol in the blood for 72 hours. No participant had detectable free gingerol or shogaol. Only their conjugated forms, bound to a glucuronide or sulfate by the liver and intestine, were present. The peak occurred around 65 to 75 minutes, and the elimination half-life was less than two hours. The body therefore transforms everything very quickly.

The pharmacokinetic data suggest so: with a peak in just over an hour and a half-life of less than two hours, a single morning dose leaves nothing measurable in the blood by afternoon. This is consistent with clinical trial protocols, which divide the dose into three or four doses throughout the day. One capsule in the morning and one in the evening follows this logic; a large single dose does not.

No, and it is measurable. Ten ginger root supplements bought at random in pharmacies and stores were analyzed. The 6-gingerol content ranged from 0.0 to 9.43 mg per gram of powder. Some contained none at all. The 6-shogaol ranged from 0.16 to 2.18 mg per gram. And the suggested daily doses on labels ranged from 250 mg to 4.77 g. Two capsules labeled ginger can therefore contain unrelated quantities of active ingredients.

Through a combination of several factors: poor raw material, a variety or harvest with low concentration, drying that was too long or too hot, which converted gingerols to shogaols then degraded these, prolonged storage, or dilution. The word ginger on the label refers to a plant, not a content. Without analysis, nothing guarantees what is in the capsule.

Through the batch certificate of analysis, which indicates the gingerol and shogaol content measured by chromatography. A serious manufacturer provides it on request. In its absence, indirect indicators are the mention of the plant part—rhizome—the form, rhizome powder rather than a blend, the origin, and the presence of a batch number. A product that specifies none of this does not allow for any verification.

Little, and especially an unknown quantity. Gingerols are poorly soluble in water, some remains in the rhizome, and the dose depends on the amount grated, the infusion time, and the temperature, which actually converts some of the gingerols to shogaols during preparation. The infusion is pleasant and may suffice for mild discomfort. It does not correspond to the doses of clinical trials and does not allow you to know what you are taking.

A standardized extract guarantees a gingerol and shogaol content, which crude powder does not guarantee without analysis. But most clinical trials used rhizome powder, not extracts, and reference doses are expressed in milligrams of powder. A concentrated extract has an unknown equivalent powder dose. Both approaches have their logic; powder analyzed batch by batch combines fidelity to trials and verification of content.

Fresh rhizome contains approximately 80 to 90% water, so one gram of dry powder corresponds roughly to 5 to 10 grams of fresh. But the comparison is misleading: drying has changed the composition, converted gingerols to shogaols, and degraded some compounds. A capsule of powder is not concentrated fresh ginger, it is a different product, richer in shogaols and above all dosable.

The cultivation method does not determine the gingerol content, which depends on the variety, maturity at harvest, terroir, and especially post-harvest processing. Organic certification guarantees the absence of synthetic pesticides, which is a real quality criterion, but distinct from content level. The two are verified separately: certification for one, analysis for the other.

Essentially dried rhizome powder in capsules, at defined doses: 250 mg four times daily in the trial on painful periods versus ibuprofen, 650 mg three times daily in the trial on pregnancy nausea versus vitamin B6, and ranges of 500 to 2,000 mg per day in meta-analyses. A few trials used syrups or biscuits. Almost none used fresh rhizome or infusion.

That fresh and dried do not contain the same molecules, drying converting gingerols to shogaols. That the body conjugates everything in less than an hour and eliminates it in less than two, which argues for divided doses. That commercial supplements range from zero to 9.43 mg/g of 6-gingerol, so the word ginger guarantees nothing. That clinical trials used dried rhizome powder in capsules at defined doses. And that the only useful question is: how many active compounds, and how verified.